WT1 PEPTIDE VACCINATION FOR MALIGNANT GLIOMAS AS A PART OF MULTI-MODAL THERAPY

BACKGROUND: We have been conducting clinical trials of peptide vaccination targeting WT1 gene product against malignant gliomas. Given the results of phase II trial for recurrent malignant gliomas (Izumoto, Hashimoto et al., J Neurosurg 2008), we performed recursive partitioning analyses (RPA) (Cars...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hashimoto, Naoya, Tsuboi, Akihiro, Chiba, Yasuyoshi, Hirayama, Ryuichi, Takano, Koji, Kijima, Noriyuki, Oka, Yoshihiro, Kagawa, Naoki, Izumoto, Shuichi, Sugiyama, Haruo, Yoshimine, Toshiki
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144609/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.60
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi